377 related articles for article (PubMed ID: 33548972)
1. Anti-PLA2R and anti-THSD7A as Diagnostic Serological Markers of Idiopathic Membranous Nephropathy: A Single Centre Study.
Fouad MA; Mahedy AW; Mansour AE; Fouad NA
Egypt J Immunol; 2020 Jun; 27(2):1-9. PubMed ID: 33548972
[TBL] [Abstract][Full Text] [Related]
2. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
Tian C; Li L; Liu T; Qu X; Qiu Y
Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
4. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers to detect membranous nephropathy in Chinese patients.
Lin L; Wang WM; Pan XX; Xu J; Gao CN; Zhang W; Ren H; Xie JY; Shen PY; Xu YW; Ni LY; Chen N
Oncotarget; 2016 Oct; 7(42):67868-67879. PubMed ID: 27634909
[TBL] [Abstract][Full Text] [Related]
7. A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy.
Wanderley DC; Jones BD; Barbosa FAM; Araujo SA
J Bras Nefrol; 2019 Oct; 42(2):254-258. PubMed ID: 31663595
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of M
Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
[TBL] [Abstract][Full Text] [Related]
9. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
[TBL] [Abstract][Full Text] [Related]
10. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
11. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
Hill PA; McRae JL; Dwyer KM
Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans.
Lwezaula BF; Ameh OI; Ekrikpo UE; Botha FC; Okpechi-Samuel US; Wearne N; Ronco P; Bello AK; Okpechi IG
BMC Nephrol; 2021 Jan; 22(1):15. PubMed ID: 33413188
[TBL] [Abstract][Full Text] [Related]
14. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
[TBL] [Abstract][Full Text] [Related]
15. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
[TBL] [Abstract][Full Text] [Related]
17. Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.
Tampoia M; Migliucci F; Villani C; Abbracciavento L; Rossini M; Fumarulo R; Gesualdo L; Montinaro V
J Nephrol; 2018 Dec; 31(6):899-905. PubMed ID: 30187382
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
19. Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA.
Kaga H; Komatsuda A; Yamamoto S; Kikuchi T; Kamata M; Sato A; Odaka M; Yokota SI; Takahashi N; Wakui H
Clin Exp Nephrol; 2019 Apr; 23(4):465-473. PubMed ID: 30756249
[TBL] [Abstract][Full Text] [Related]
20. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity.
Larsen CP; Cossey LN; Beck LH
Mod Pathol; 2016 Apr; 29(4):421-6. PubMed ID: 26847174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]